Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 16966563.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors studied the acute effect of caffeine on the levodopa pharmacokinetics and pharmacodynamics in 12 patients with idiopathic Parkinson disease. This double-blind, randomized, crossover study revealed that caffeine shortened the maximal plasma concentration of levodopa, decreased the latency to levodopa walking and tapping motor response, and increased the magnitude of walking response. Caffeine administered before levodopa may improve its pharmacokinetics in some parkinsonian patients.
Medical subject headings
- Antiparkinson Agents
- Caffeine
- Central Nervous System Stimulants
- Levodopa
- Parkinson Disease